Bionano Genomics, Inc. Shareholders' Equity
Bionano Genomics, Inc. (BNGO) had Shareholders' Equity of $31.61 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $31.61M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $37.46M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $44.42M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $49.80M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $31.61M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $37.46M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $44.42M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $49.80M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $45.37M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $48.19M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $35.38M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $48.86M 10-Q · filed 2025-11-13 | $48.87M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $80.33M 10-Q · filed 2025-11-13 | $80.34M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $82.77M 10-Q · filed 2025-11-13 | $82.77M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $96.16M 10-K · filed 2026-03-23 | |
| 2023-09-30 | $119.00M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $214.76M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $231.49M 10-Q · filed 2024-11-14 | $231.49M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $249.40M 10-K · filed 2025-03-31 | $249.40M 10-K · filed 2023-03-09 |
| 2022-09-30 | $281.74M 10-Q · filed 2023-11-08 | $281.74M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $284.73M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $311.19M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $337.12M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $341.56M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $345.87M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $362.72M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $35.08M 10-K · filed 2023-03-09 | $35.08M 10-K · filed 2021-03-23 |
| 2020-09-30 | $14.68M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $5.84M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | -$4.21M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $3.61M 10-K · filed 2022-03-01 | $3.61M 10-K · filed 2020-03-10 |
| 2019-09-30 | -$7.38M 10-Q · filed 2020-11-13 | -$7.38M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$1.34M 10-Q · filed 2020-11-13 | -$1.34M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.87M 10-Q · filed 2020-11-13 | $5.87M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $10.14M 10-K · filed 2021-03-23 | |
| 2018-09-30 | $15.24M 10-Q · filed 2019-11-07 | $15.24M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$57.28M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | -$54.02M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | -$50.23M 10-K · filed 2020-03-10 | |
| 2016-12-31 | -$27.26M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |